多年来,人们一直以血浆总胆固醇及甘油三酯的浓度变化来反映脂类代谢及其运转情况,并用以推测分析冠心病的致病因素。1951年Barrs′首次确定高密度脂蛋白(HDL)与心血管疾病危险性呈负相关。但HDL的分离不易在一般实验室推行。近年来,国外多采用化学沉淀法测定血浆HDLCH水平来代表HDL水平。通过流行病学的广泛调查研究,现已明确HDL-CH降低是冠心病发病的 Over the years, people have been to changes in plasma total cholesterol and triglyceride concentrations to reflect lipid metabolism and its functioning, and used to speculate analysis of coronary heart disease risk factors. Barrs’ first confirmed in 1951 a negative correlation between high-density lipoprotein (HDL) and the risk of cardiovascular disease. However, the separation of HDL is not easy in the general laboratory. In recent years, more foreign countries using chemical precipitation HDLCH plasma levels to represent the level of HDL. Extensive research by epidemiology, it has been clear that the reduction of HDL-CH is the incidence of coronary heart disease